⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10929466 | 0.62 | — | — | |
| SCHEMBL15510742 | 0.50 | — | — | |
| SCHEMBL6998282 | 0.50 | — | — | |
| SCHEMBL3637558 | 0.44 | — | — | |
| SCHEMBL2554291 | 0.44 | — | — | |
| SCHEMBL3918390 | 0.42 | — | — | |
| SCHEMBL39285 | 0.42 | — | — | |
| SCHEMBL13255034 | 0.42 | — | — | |
| SCHEMBL1190870 | 0.38 | — | — | |
| SCHEMBL4175824 | 0.35 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716453-A | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-109942560-B | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-06-17 | — | — | CN | disclosed |
| WO-2019194858-A1 | MODULAR SYNTHESIS OF AMINOGLYCOSIDES | ACHAOGEN, INC. (US) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019046126-A1 | AMINOGLYCOSIDES AND USES THEREOF | ACHAOGEN, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| EP-2590968-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | Novartis AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-2424851-A1 | METHODS FOR THE SYNTHESIS OF AMRUBICIN | TBD-BioDiscovery (EE) | 2012-03-07 | — | — | EP | disclosed |
| WO-2012004217-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010125466-A1 | METHODS FOR THE SYNTHESIS OF AMRUBICIN | TBD-BIODISCOVERY (EE) | 2010-11-04 | — | — | WO | disclosed |